6533b7d7fe1ef96bd1268615
RESEARCH PRODUCT
Recent clinical evidence on metronomic dosing in controlled clinical trials: a systematic literature review.
Viktor WichmannAntti JekunenJatta SaarenheimoNatalja Eigelienesubject
medicine.medical_specialtymedicine.medical_treatmentAntineoplastic Agents030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineClinical Trials Phase II as TopicNeoplasmsAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansRadiology Nuclear Medicine and imagingDosingIntensive care medicineRandomized Controlled Trials as TopicChemotherapybusiness.industryLow doseHematologyGeneral MedicineProgression-Free SurvivalCancer treatmentClinical trialSurvival RateSystematic reviewOncologyClinical Trials Phase III as TopicClinical evidence030220 oncology & carcinogenesisAdministration Metronomicbusinessdescription
Introduction: Metronomic dosing is used to give continuous chemotherapy at low doses. The low doses have minimal side effects and may enable cancer treatment to be remodeled toward the management o...
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2020-04-11 | Acta oncologica (Stockholm, Sweden) |